Kommentar
In symptomatic AF, cryoballoon ablation reduced progression to persistent AF vs. antiarrhythmic therapy at 3 y
Annals of Internal Medicine · 2023
DOI: 10.7326/j23-0008 ↗Kurz gefasst
Kommentar in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von Nigel S Tan. Beteiligte Einrichtung: McMaster University; Niagara Health System; Hamilton Health Sciences, St. Catharines, Ontario, Canada (N.S.T.). Hauptthemen laut MEDLINE: Cryosurgery, Atrial Fibrillation, Catheter Ablation, Pulmonary Veins.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
CryosurgeryAtrial FibrillationCatheter AblationPulmonary VeinsHumansTreatment OutcomeAnti-Arrhythmia AgentsRecurrence
Substanzen
Anti-Arrhythmia Agents
Autor:innen und Institutionen
- McMaster University; Niagara Health System; Hamilton Health Sciences, St. Catharines, Ontario, Canada (N.S.T.).
Zitieren
APA
Tan, N. S. (2023). In symptomatic AF, cryoballoon ablation reduced progression to persistent AF vs. antiarrhythmic therapy at 3 y. Annals of Internal Medicine. https://doi.org/10.7326/j23-0008
Vancouver
Tan NS. In symptomatic AF, cryoballoon ablation reduced progression to persistent AF vs. antiarrhythmic therapy at 3 y. Annals of Internal Medicine. 2023. doi:10.7326/j23-0008
BibTeX
@article{Tan2023,
author = {Tan, Nigel S},
title = {In symptomatic AF, cryoballoon ablation reduced progression to persistent AF vs. antiarrhythmic therapy at 3 y},
journal = {Annals of Internal Medicine},
year = {2023},
doi = {10.7326/j23-0008}
}
EUVIMED